Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2017

November 2017 | 114 pages | ID: G0E454B1E48EN
QYResearch

Abstracts

This report studies Next Generation Cancer Diagnostic Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Roche Holding Ltd.（Switzerland)
• Abbott Laboratories(US)
• Siemens Healthcare(Germany)
• Agilent Technologies Inc(Germany)
• Illumina Inc.(US)
• Becton Dickinson and Co.(US)
• QIAGEN N.V.(Germany)
• Affymetrix Inc.(US)
• Johnson & Johnson(US)
• Thermo Fisher Scientific Inc.(US)
• GE Healthcare(England)
• Life Technologies Corp.(US)
• Luminex Corp.(US)
• Cepheid Inc.(US)
• Allegro Diagnostics Corp.(Brazil)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays

By Application, the market can be split into

• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES

1.1 Definition and Specifications of Next Generation Cancer Diagnostic Devices
  1.1.1 Definition of Next Generation Cancer Diagnostic Devices
  1.1.2 Specifications of Next Generation Cancer Diagnostic Devices
1.2 Classification of Next Generation Cancer Diagnostic Devices
  1.2.1 Next Generation Sequencing
  1.2.2 qPCR & Multiplexing
  1.2.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
  1.2.4 Protein Microarrays
  1.2.5 DNA Microarrays
1.3 Applications of Next Generation Cancer Diagnostic Devices
  1.3.1 Biomarker Development
  1.3.2 CTC Analysis
  1.3.3 Proteomic Analysis
  1.3.4 Epigenetic Analysis
  1.3.5 Genetic Analysis
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices
2.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
2.4 Industry Chain Structure of Next Generation Cancer Diagnostic Devices

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES

3.1 Capacity and Commercial Production Date of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016

4 GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Next Generation Cancer Diagnostic Devices Capacity and Growth Rate Analysis
  4.2.2 2016 Next Generation Cancer Diagnostic Devices Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate Analysis
  4.3.2 2016 Next Generation Cancer Diagnostic Devices Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Next Generation Cancer Diagnostic Devices Sales Price
  4.4.2 2016 Next Generation Cancer Diagnostic Devices Sales Price Analysis (Company Segment)

5 NEXT GENERATION CANCER DIAGNOSTIC DEVICES REGIONAL MARKET ANALYSIS

5.1 North America Next Generation Cancer Diagnostic Devices Market Analysis
  5.1.1 North America Next Generation Cancer Diagnostic Devices Market Overview
  5.1.2 North America 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.1.4 North America 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
5.2 China Next Generation Cancer Diagnostic Devices Market Analysis
  5.2.1 China Next Generation Cancer Diagnostic Devices Market Overview
  5.2.2 China 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.2.4 China 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
5.3 Europe Next Generation Cancer Diagnostic Devices Market Analysis
  5.3.1 Europe Next Generation Cancer Diagnostic Devices Market Overview
  5.3.2 Europe 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.3.4 Europe 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
5.4 Southeast Asia Next Generation Cancer Diagnostic Devices Market Analysis
  5.4.1 Southeast Asia Next Generation Cancer Diagnostic Devices Market Overview
  5.4.2 Southeast Asia 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.4.4 Southeast Asia 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
5.5 Japan Next Generation Cancer Diagnostic Devices Market Analysis
  5.5.1 Japan Next Generation Cancer Diagnostic Devices Market Overview
  5.5.2 Japan 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.5.4 Japan 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
5.6 India Next Generation Cancer Diagnostic Devices Market Analysis
  5.6.1 India Next Generation Cancer Diagnostic Devices Market Overview
  5.6.2 India 2012-2017E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price Analysis
  5.6.4 India 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis

6 GLOBAL 2012-2017E NEXT GENERATION CANCER DIAGNOSTIC DEVICES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Next Generation Cancer Diagnostic Devices Sales by Type
6.2 Different Types of Next Generation Cancer Diagnostic Devices Product Interview Price Analysis
6.3 Different Types of Next Generation Cancer Diagnostic Devices Product Driving Factors Analysis
  6.3.1 Next Generation Sequencing of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  6.3.2 qPCR & Multiplexing of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  6.3.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  6.3.4 Protein Microarrays of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  6.3.5 DNA Microarrays of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NEXT GENERATION CANCER DIAGNOSTIC DEVICES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Next Generation Cancer Diagnostic Devices Consumption by Application
7.2 Different Application of Next Generation Cancer Diagnostic Devices Product Interview Price Analysis
7.3 Different Application of Next Generation Cancer Diagnostic Devices Product Driving Factors Analysis
  7.3.1 Biomarker Development of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  7.3.2 CTC Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  7.3.3 Proteomic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  7.3.4 Epigenetic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
  7.3.5 Genetic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES

8.1 Roche Holding Ltd.(Switzerland)
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Roche Holding Ltd.(Switzerland) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Roche Holding Ltd.(Switzerland) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.2 Abbott Laboratories(US)
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Abbott Laboratories(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Abbott Laboratories(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.3 Siemens Healthcare(Germany)
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Siemens Healthcare(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Siemens Healthcare(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.4 Agilent Technologies Inc(Germany)
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Agilent Technologies Inc(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Agilent Technologies Inc(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.5 Illumina Inc.(US)
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Illumina Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Illumina Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.6 Becton Dickinson and Co.(US)
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Becton Dickinson and Co.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Becton Dickinson and Co.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.7 QIAGEN N.V.(Germany)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 QIAGEN N.V.(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 QIAGEN N.V.(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.8 Affymetrix Inc.(US)
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Affymetrix Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Affymetrix Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.9 Johnson & Johnson(US)
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Johnson & Johnson(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Johnson & Johnson(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.10 Thermo Fisher Scientific Inc.(US)
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Thermo Fisher Scientific Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Thermo Fisher Scientific Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
8.11 GE Healthcare(England)
8.12 Life Technologies Corp.(US)
8.13 Luminex Corp.(US)
8.14 Cepheid Inc.(US)
8.15 Allegro Diagnostics Corp.(Brazil)

9 DEVELOPMENT TREND OF ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET

9.1 Global Next Generation Cancer Diagnostic Devices Market Trend Analysis
  9.1.1 Global 2017-2022 Next Generation Cancer Diagnostic Devices Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Next Generation Cancer Diagnostic Devices Sales Price Forecast
9.2 Next Generation Cancer Diagnostic Devices Regional Market Trend
  9.2.1 North America 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
  9.2.2 China 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
  9.2.3 Europe 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
  9.2.5 Japan 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
  9.2.6 India 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
9.3 Next Generation Cancer Diagnostic Devices Market Trend (Product Type)
9.4 Next Generation Cancer Diagnostic Devices Market Trend (Application)

10 NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKETING TYPE ANALYSIS

10.1 Next Generation Cancer Diagnostic Devices Regional Marketing Type Analysis
10.2 Next Generation Cancer Diagnostic Devices International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Next Generation Cancer Diagnostic Devices by Region
10.4 Next Generation Cancer Diagnostic Devices Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Next Generation Cancer Diagnostic Devices
Table Product Specifications of Next Generation Cancer Diagnostic Devices
Table Classification of Next Generation Cancer Diagnostic Devices
Figure Global Production Market Share of Next Generation Cancer Diagnostic Devices by Type in 2016
Figure Next Generation Sequencing Picture
Table Major Manufacturers of Next Generation Sequencing
Figure qPCR & Multiplexing Picture
Table Major Manufacturers of qPCR & Multiplexing
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Picture
Table Major Manufacturers of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Figure Protein Microarrays Picture
Table Major Manufacturers of Protein Microarrays
Figure DNA Microarrays Picture
Table Major Manufacturers of DNA Microarrays
Table Applications of Next Generation Cancer Diagnostic Devices
Figure Global Consumption Volume Market Share of Next Generation Cancer Diagnostic Devices by Application in 2016
Figure Biomarker Development Examples
Table Major Consumers in Biomarker Development
Figure CTC Analysis Examples
Table Major Consumers in CTC Analysis
Figure Proteomic Analysis Examples
Table Major Consumers in Proteomic Analysis
Figure Epigenetic Analysis Examples
Table Major Consumers in Epigenetic Analysis
Figure Genetic Analysis Examples
Table Major Consumers in Genetic Analysis
Figure Market Share of Next Generation Cancer Diagnostic Devices by Regions
Figure North America Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Figure China Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Figure Europe Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Figure Japan Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Figure India Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2012-2022)
Table Next Generation Cancer Diagnostic Devices Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices in 2016
Figure Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure Industry Chain Structure of Next Generation Cancer Diagnostic Devices
Table Capacity and Commercial Production Date of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Next Generation Cancer Diagnostic Devices 2012-2017
Figure Global 2012-2017E Next Generation Cancer Diagnostic Devices Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Next Generation Cancer Diagnostic Devices Market Size (Value) and Growth Rate
Table 2012-2017E Global Next Generation Cancer Diagnostic Devices Capacity and Growth Rate
Table 2016 Global Next Generation Cancer Diagnostic Devices Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) and Growth Rate
Table 2016 Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Table 2016 Global Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure North America 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure North America 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure China 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure China 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure Europe 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure Europe 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure Southeast Asia 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure Japan 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure Japan 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices 2012-2017E
Figure India 2012-2017E Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs)
Figure India 2016 Next Generation Cancer Diagnostic Devices Sales Market Share
Table Global 2012-2017E Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type
Table Different Types Next Generation Cancer Diagnostic Devices Product Interview Price
Table Global 2012-2017E Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application
Table Different Application Next Generation Cancer Diagnostic Devices Product Interview Price
Table Roche Holding Ltd.（Switzerland) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Abbott Laboratories(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Siemens Healthcare(Germany) Information List
Table Product A Overview
Table Product B Overview
Table 2015 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Agilent Technologies Inc(Germany) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Illumina Inc.(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Becton Dickinson and Co.(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table QIAGEN N.V.(Germany) Information List
Table Product A Overview
Table Product B Overview
Table 2016 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Affymetrix Inc.(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Johnson & Johnson(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table Thermo Fisher Scientific Inc.(US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Business Region Distribution
Table GE Healthcare(England) Information List
Table Life Technologies Corp.(US) Information List
Table Luminex Corp.(US) Information List
Table Cepheid Inc.(US) Information List
Table Allegro Diagnostics Corp.(Brazil) Information List
Figure Global 2017-2022 Next Generation Cancer Diagnostic Devices Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Next Generation Cancer Diagnostic Devices Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Next Generation Cancer Diagnostic Devices Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Next Generation Cancer Diagnostic Devices by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Next Generation Cancer Diagnostic Devices by Application 2017-2022
Table Traders or Distributors with Contact Information of Next Generation Cancer Diagnostic Devices by Region